IL129408A - גבישי סצפלוספורין ותהליך להכנתם - Google Patents
גבישי סצפלוספורין ותהליך להכנתםInfo
- Publication number
- IL129408A IL129408A IL12940898A IL12940898A IL129408A IL 129408 A IL129408 A IL 129408A IL 12940898 A IL12940898 A IL 12940898A IL 12940898 A IL12940898 A IL 12940898A IL 129408 A IL129408 A IL 129408A
- Authority
- IL
- Israel
- Prior art keywords
- cephalosporin
- alcohol
- crystals
- crystals according
- preparing
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 63
- 229930186147 Cephalosporin Natural products 0.000 title claims abstract description 61
- 229940124587 cephalosporin Drugs 0.000 title claims abstract description 61
- 150000001780 cephalosporins Chemical class 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title description 7
- -1 p-methoxybenzyl Chemical group 0.000 claims abstract description 7
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 description 30
- 239000000243 solution Substances 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 12
- 229960001139 cefazolin Drugs 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- KFCMZNUGNLCSJQ-GWQXNCQPSA-N (4-methoxyphenyl)methyl (6r)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)C1=C(CCl)CS[C@H]2N1C(=O)C2NC(=O)CC1=CC=CC=C1 KFCMZNUGNLCSJQ-GWQXNCQPSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000003951 lactams Chemical group 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- BCMPVBNNIHFSLU-ITCMONMYSA-N benzhydryl (6r)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H]2N(C1=O)C(=C(CS2)CCl)C(=O)OC(C=1C=CC=CC=1)C=1C=CC=CC=1)NC(=O)CC1=CC=CC=C1 BCMPVBNNIHFSLU-ITCMONMYSA-N 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XCXHTOCPOYVNNZ-NRWPOFLRSA-N (4-methoxyphenyl)methyl (6r)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)C(N1C(=O)C(NC(=O)CC=2C=CC=CC=2)[C@H]1SC1)=C1CSC1=NN=C(C)S1 XCXHTOCPOYVNNZ-NRWPOFLRSA-N 0.000 description 1
- JKSGJOGGZPWNTE-FBMWCMRBSA-N (6r)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)C(NC(=O)CC=3C=CC=CC=3)[C@H]2SC1 JKSGJOGGZPWNTE-FBMWCMRBSA-N 0.000 description 1
- HJSGHKMSDOLGJJ-IOJJLOCKSA-N (6r)-7-amino-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)C(N)[C@H]2SC1 HJSGHKMSDOLGJJ-IOJJLOCKSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- HOKIDJSKDBPKTQ-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[(5-amino-5-carboxypentanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C12 HOKIDJSKDBPKTQ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- QSNFBVOXGLTBFG-WPZCJLIBSA-N COC1=CC=C(COC(=O)C2=CC(S[C@H]3N2C(C3)=O)CCl)C=C1 Chemical compound COC1=CC=C(COC(=O)C2=CC(S[C@H]3N2C(C3)=O)CCl)C=C1 QSNFBVOXGLTBFG-WPZCJLIBSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-M cefazolin(1-) Chemical compound S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-M 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22814797 | 1997-08-25 | ||
| PCT/JP1998/003664 WO1999010352A1 (en) | 1997-08-25 | 1998-08-19 | Cephalosporin crystals and process for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL129408A0 IL129408A0 (en) | 2000-02-17 |
| IL129408A true IL129408A (he) | 2004-01-04 |
Family
ID=16871973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12940898A IL129408A (he) | 1997-08-25 | 1998-08-19 | גבישי סצפלוספורין ותהליך להכנתם |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20020099206A1 (he) |
| EP (1) | EP0963989A4 (he) |
| KR (1) | KR100367564B1 (he) |
| CN (1) | CN1090635C (he) |
| AU (1) | AU728627B2 (he) |
| CA (1) | CA2269286A1 (he) |
| IL (1) | IL129408A (he) |
| WO (1) | WO1999010352A1 (he) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4953501B2 (ja) * | 1999-09-30 | 2012-06-13 | 大塚化学株式会社 | ３−セフェム誘導体結晶の製造方法 |
| EP1666483B1 (en) | 2003-09-09 | 2011-08-17 | Nippon Chemical Industrial Company Limited | Process for producing 3-chloromethyl-3-cephem derivative |
| US7157574B2 (en) | 2004-03-25 | 2007-01-02 | Nippon Chemical Industrial Co., Ltd. | Process for preparing crystalline 3-chloromethyl-3-cephem derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2176216A5 (he) * | 1972-03-14 | 1973-10-26 | Glaenzer Spicer Sa | |
| JPS5874689A (ja) * | 1981-10-29 | 1983-05-06 | Otsuka Chem Co Ltd | ３−クロロメチル−３−セフエム誘導体の製造法 |
| IT1214587B (it) * | 1986-12-23 | 1990-01-18 | Giovanni Bonfanti | Metodo per la produzione diprodotti cristallini puri. |
| JP2750355B2 (ja) * | 1988-05-11 | 1998-05-13 | 大塚化学株式会社 | ３−エキソメチレンセファム誘導体の製造法 |
| IT1251999B (it) * | 1991-11-11 | 1995-05-27 | Opos Biochimica Srl | Forma cristallina di un antibiotico cefalosporinico |
-
1998
- 1998-08-19 IL IL12940898A patent/IL129408A/he not_active IP Right Cessation
- 1998-08-19 WO PCT/JP1998/003664 patent/WO1999010352A1/ja not_active Ceased
- 1998-08-19 AU AU87468/98A patent/AU728627B2/en not_active Expired
- 1998-08-19 CN CN98801211A patent/CN1090635C/zh not_active Ceased
- 1998-08-19 EP EP98938886A patent/EP0963989A4/en not_active Withdrawn
- 1998-08-19 KR KR10-1999-7003429A patent/KR100367564B1/ko not_active Expired - Lifetime
- 1998-08-19 CA CA002269286A patent/CA2269286A1/en not_active Abandoned
-
2002
- 2002-01-09 US US10/040,365 patent/US20020099206A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2269286A1 (en) | 1999-03-04 |
| EP0963989A4 (en) | 2000-10-25 |
| KR100367564B1 (ko) | 2003-01-14 |
| IL129408A0 (en) | 2000-02-17 |
| US20020099206A1 (en) | 2002-07-25 |
| CN1090635C (zh) | 2002-09-11 |
| AU8746898A (en) | 1999-03-16 |
| WO1999010352A1 (en) | 1999-03-04 |
| AU728627B2 (en) | 2001-01-11 |
| CN1237181A (zh) | 1999-12-01 |
| KR20000068797A (ko) | 2000-11-25 |
| HK1025951A1 (en) | 2000-12-01 |
| EP0963989A1 (en) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69816056T2 (de) | Kristallinisches aminsalz von cefdinir | |
| US4252951A (en) | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid | |
| KR100377159B1 (ko) | 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법 | |
| DK156069B (da) | Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf | |
| AU655718B2 (en) | Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof | |
| EP1546155B1 (en) | Intermediate cefdinir salts | |
| EP3169692A1 (en) | A new form of sofosbuvir and a method of its preparation | |
| CA1285554C (en) | Method for preparing crystalline cefadroxil monohydrate | |
| US4003896A (en) | Method of preparing a sparingly soluble complex of cephalexin | |
| EP0963989A1 (en) | Cephalosporin crystals and process for producing the same | |
| GB2421024A (en) | Cefdinir crystalline form C | |
| RU2130456C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ МОНОГИДРАТНОЙ ФОРМЫ β-ЛАКТАМА | |
| KR20050099548A (ko) | 카르바페넴 중간체의 결정 | |
| DE2429166A1 (de) | Verfahren zur selektiven spaltung der amidsaeurefunktion eines 7-(amidsaeure)cephalosporins | |
| KR20050035178A (ko) | 알킬- 또는 아릴-술포네이트를 경유한 세픽심의 제조방법 | |
| EP2030977A1 (en) | Improved method for crystallization of azetidinonecarboxylic acid | |
| DE2550867C2 (de) | Verfahren zur Herstellung von 7β-Benzylidenamino-7α-methoxy-3-cephem-Verbindungen | |
| EP1730153B1 (en) | Isopropanol water solvate of olanzapine | |
| JPS59104390A (ja) | １−オキサ−β−ラクタムの製造法 | |
| US20100179318A1 (en) | Process to make lestaurtinib | |
| JP2661810B2 (ja) | ７−アミノ−３−クロロメチル−３−セフェム誘導体の製法 | |
| NZ204930A (en) | Crystalline sodium cefoperazone and its preparation | |
| GB2218095A (en) | Cepholosporin isomerisation | |
| DE3914658A1 (de) | Chemisches verfahren | |
| DE60313124T2 (de) | Verfahren zur herstellung einer 1,2,3-triazolverbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |